Revolutionizing Healthcare: Addressing Loneliness and Social Health with Papa

VIDEO EMBED:

 

In an era where healthcare is rapidly evolving, the Healthcare Rethink podcast by FinThrive delves into innovative approaches to address critical aspects of health beyond the clinical. Host Brian Urban engages with Andrew Parker, CEO of Papa, in a thought-provoking discussion that transcends traditional healthcare boundaries in efforts to address loneliness and social health.

This episode, titled “Big Paps Is in the House,” features a deep dive into how Papa addresses loneliness while focusing on the social determinants of health — a crucial aspect often overlooked in traditional healthcare settings. The discussion touches on the innovative strategies employed by Papa to integrate its services into Medicare Advantage plans and other health systems, highlighting the importance of personalized, human-centered care.

As the healthcare industry grapples with challenges like loneliness and social health, this episode of Healthcare Rethink offers valuable insights into how companies like Papa are leading the charge in transforming healthcare delivery.

Article written by MarketScale.

Recent Episodes

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

In this episode of Care Anywhere, host Lea Sims sits down with Nigerian nurse entrepreneur and advocate Obafemi Arowosegbe to discuss leadership, mentorship, and the future of nursing in Africa. While still a nursing student, Obafemi founded the Nightingale Summit, a growing conference designed to empower nursing students and early-career nurses with leadership skills,…

The rapid expansion of precision medicine, biologics, and targeted cancer therapies is transforming oncology—but it’s also overwhelming a system not built to keep pace. In the U.S., cancer drugs now account for some of the highest-cost treatments in healthcare, and with that has come a surge in prior authorization requirements and denials. Studies suggest physicians…